ConsumerHealth

Pfizer Prepares to Divest Final Share of Haleon as Strategic Shift Takes Shape

15 days ago

Pfizer Inc. is making significant moves as it aims to fully divest its stake in Haleon, the consumer healthcare business it previously shared with GlaxoSmithKline (GSK). The pharmaceutical giant has announced plans to execute a final sale of its shareholding in Haleon, a move that signifies a strategic shift as Pfizer refocuses on enhancing its core pharmaceutical and vaccine operations.

Johnson & Johnson Faces Crucial Bankruptcy Court Showdown: What’s at Stake for the Healthcare Giant

1 month ago

In an unfolding legal saga, Johnson & Johnson (J&J), the healthcare behemoth known for its diverse array of consumer health products, is gearing up for a significant courtroom battle regarding its controversial bankruptcy strategy. This high-stakes situation centers around J&J’s attempt to resolve a massive array of legal claims linked to its talc-based products, which have been alleged to cause cancer. The company has faced thousands of lawsuits from claimants alleging that its talcum powder has resulted in health issues, primarily ovarian cancer and mesothelioma.

Kenvue Faces Challenges as Sales Fall Short of Expectations Amid Weak Volume for Tylenol

2 months ago

Kenvue, the consumer health division of Johnson & Johnson, has recently reported disappointing sales results that failed to meet Wall Street's projections. This trend has raised concerns among investors regarding the company's performance, particularly its flagship products like Tylenol, which are experiencing declining volumes in the market.

A2 Milk Finally Set to Reward Investors with Dividends After Years of Growth

4 months ago

In a major update for shareholders, New Zealand-based A2 Milk Company has announced plans to initiate dividend payments starting from its upcoming financial year. This decision comes as the company aims to return a portion of its profits to investors who have supported the brand since its inception.

FDA Discovers Bacterial Contamination in Tom's of Maine Toothpaste

4 months ago

In a startling revelation, the U.S. Food and Drug Administration (FDA) has found potentially harmful bacteria in a specific batch of Tom's of Maine toothpaste, leading to raised concerns among consumers and health officials alike. The discovery has prompted immediate actions from the company and calls for enhanced regulations in the natural products industry.

Kenvue Faces Pressure as Weak Sales Fuel Activist Investor Battle

5 months ago

Kenvue Holdings, the consumer health subsidiary of Johnson & Johnson, has recently reported disappointing sales results that have intensified the ongoing confrontations with Starboard Value, a prominent activist investment firm. The latest quarterly results revealed a decline in product sales, further complicating Kenvue's efforts to stabilize its market position following its split from J&J earlier this year.

Starboard Value Takes Stake in Kenvue, Pushing for Strategic Changes

5 months ago

In a development that has caught the eye of investors and market analysts alike, activist investment firm Starboard Value has acquired a significant stake in Kenvue Inc., the consumer health division spun off from Johnson & Johnson. This move signals Starboard’s ambition to implement strategic changes within the company to enhance its performance and shareholder value, according to a report published by The Wall Street Journal.

The Rise of Kratom: Navigating a $1 Billion Legal Gray Area

6 months ago

Kratom has been one of the most controversial plants of interest in recent years, morphing into a billion-dollar industry inside a comfortable legal gray area. Once a Southeast Asian botanical, kratom has transitioned from a simple herbal remedy into a modern-day health trend with the increasing fascination of many consumers, health advocates, and regulators.